Home » FUJI PHARMA, JCR PHARMACEUTICALS DISSOLVE PARTNERSHIP IN RENAL ANEMIA DRUG DEVELOPMENT
FUJI PHARMA, JCR PHARMACEUTICALS DISSOLVE PARTNERSHIP IN RENAL ANEMIA DRUG DEVELOPMENT
Fuji Pharma has agreed with JCR Pharmaceuticals to terminate their joint development contract for JR-013, a drug candidate for treating renal anemia. Since November 2004, the two companies have collaborated in R&D for the candidate. However, the two companies have disagreed on the direction of development, future budget plans and related rights. Fuji Pharma will halt the development of JR-013. Meanwhile, JCR Pharmaceuticals will conduct clinical trials as originally planned with a view to forming a partnership with other companies.
Japan Corporate News Network (http://www.japancorp.net/Article.Asp?Art_ID=11310)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May